My Companies
Notification
Account
Log Out
Back

Caplin Point Receives US FDA OAI Classification For Gummidipoondi Facility


17 November 2026
Caplin Point Laboratories Ltd.

US FDA classified Aug 13-21 inspection of Caplin Steriles Gummidipoondi injectable/ophthalmic plant as OAI after 10 procedural observations; company says no material impact, plant continues supplies.


Recent Events

Company Information